Teva tries again to stop generic Copaxone

A board to discuss the Multiple Sclerosis modifying drug Copaxone

Teva tries again to stop generic Copaxone

Postby MSUK » Tue Dec 14, 2010 1:30 am


Regulators in the USA have received another citizen petition from Teva Pharmaceutical Industries questioning the criteria for assessing generic versions of its multiple sclerosis blockbuster Copaxone.

The Israeli firm is asking the US Food and Drug Administration to refuse to approve any abbreviated New Drug Application for a“purported generic version” of Copaxone (glatiramer acetate) based primarily on “the inability to establish acceptable ‘sameness’ of the active ingredients”. Teva says its request should be upheld due to “the complexity of the mechanism of action of a glatiramoid and the inapplicability of leveraging conventional pharmacokinetic and pharmacodynamic testing methods to demonstrate bioequivalence”................... Read More - ... ageid=1903
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to Copaxone


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service